The online tool is available for cancer programs.
Rockville, MD – The Association of Community Cancer Centers (ACCC) has just released a model framework for cancer care providers to use in improving care coordination for lung cancer patients covered by Medicaid. “Improving Care Coordination: A Model for Lung Cancer” is a first-of-its-kind quality improvement tool, now available to cancer programs and practices nationwide.
The Model is based upon an extensive research process and addresses lung cancer care for the patient populations enrolled in Medicaid, as these patients experience more negative lung cancer outcomes.
Led by co-principal investigators Christopher Lathan, MD, MS, MPH, Medical Director, Dana-Farber at St. Elizabeth’s Medical Center, and Randall Oyer, MD, Medical Director, Ann B. Barshinger Cancer institute, Penn Medicine Lancaster General Health, the model was developed through peer-to-peer collaboration between industry researchers, lung cancer experts, oncology providers, administrators, epidemiologists, and patient advocates among the project’s Advisory Committee and Technical Expert Panel.
“The number-one deadliest cancer hits this patient population particularly hard for a number of reasons. We were looking to create a central hub where cancer centers could assess their care in specific areas and then access resources to improve those areas of their program,” said Lathan.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More